Andrew Booth

Insider Reports History

Entity
Individual
Location
C/O Abcellera Biologics Inc., 2215 Yukon Street, Vancouver, British Columbia, Canada
Signature
Tryn Stimart, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Booth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AbCellera Biologics Inc. Chief Financial Officer Common Shares 153K $413K $2.70 May 26, 2023 Direct
AbCellera Biologics Inc. Chief Financial Officer Common Shares 131K $354K $2.70 May 26, 2023 By spouse
AbCellera Biologics Inc. Chief Financial Officer Share option (right to buy) 6.59M Jan 14, 2024 Direct

Insider Reports Filed by Andrew Booth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABCL AbCellera Biologics Inc. Jan 14, 2024 1 $0 4 Jan 16, 2024 Chief Financial Officer
ABCL AbCellera Biologics Inc. May 26, 2023 1 $99.3K 4 May 26, 2023 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 20, 2022 3 $9.5K 4 Dec 22, 2022 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 1, 2022 1 $0 4 Dec 5, 2022 Chief Financial Officer
ABCL AbCellera Biologics Inc. May 12, 2022 1 $492K 4 May 16, 2022 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 31, 2021 1 $0 5 Feb 3, 2022 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 10, 2021 2 $160K 4 Dec 10, 2021 Chief Financial Officer
ABCL AbCellera Biologics Inc. Dec 7, 2021 1 $0 4 Dec 9, 2021 Chief Financial Officer
ABCL AbCellera Biologics Inc. Nov 11, 2021 2 $993K 4 Nov 15, 2021 Chief Financial Officer
ABCL AbCellera Biologics Inc. Jun 9, 2021 1 -$30.6M 4 Jun 10, 2021 Chief Financial Officer
ABCL AbCellera Biologics Inc. Jun 7, 2021 4 $306K 4 Jun 9, 2021 Chief Financial Officer